Loading...

Joel Baumgartner

TitleAssistant Clinical Professor
InstitutionUniversity of California San Diego
DepartmentSurgery
Address9500 Gilman Drive #0987
La Jolla CA 92093
Phone858-246-0581
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Joel M. Baumgartner, MD is a surgical oncologist with expertise in cancers of the GI tract and melanoma. He is board certified in general surgery and completed a surgical oncology fellowship at the University of Pittsburgh with a focus on clinical research, which included additional training in the development and conduct of clinical trials.

    Dr. Baumgartner has specific expertise and interest in treating tumors that have metastasized to the abdomen, using a promising treatment known as the “chemo bath" or hyperthermic (heated) intraperitoneal chemotherapy (HIPEC). This treatment involves surgical resection of all tumors followed by circulation of heated chemotherapy throughout the abdomen. This technique avoids many of the toxicities associated with systemic chemotherapy, while exposing the abdomen to higher concentrations of chemotherapy. Dr. Baumgartner spent two years working and training at one of highest volume HIPEC centers in the world at the University of Pittsburgh and therefore has significant experience with this procedure.

    Dr. Baumgartner also treats melanoma and performs wide local excision of these tumors, sentinel lymph node biopsies and lymph node dissections.

    Dr. Baumgartner is a member of numerous societies including the Society of Surgical Oncology, the American Society of Clinical Oncology and is an associate member of the American Association for Cancer Research and the American College of Surgeons. His research interests are in clinical trials, HIPEC, melanoma and immunotherapy.


    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Nguyen V, Marmor RA, Ramamoorthy SL, Costantini TW, Baumgartner J, Berumen J, Jacobsen GR, Sicklick JK. The Use of Solicited Publishing by Academic Surgeons. Surgery. 2018 Apr 30. PMID: 29724409.
      View in: PubMed
    2. Weiss A, Ward EP, Baumgartner J, Lowy AM, Kelly KJ. Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients. World J Surg Oncol. 2018 Apr 26; 16(1):87. PMID: 29699564.
      View in: PubMed
    3. Liu Y, Yonemura Y, Levine EA, Glehen O, Goere D, Elias D, Morris DL, Sugarbaker PH, Tuech JJ, Cashin P, Spiliotis JD, de Hingh I, Ceelen W, Baumgartner J, Piso P, Katayama K, Deraco M, Kusamura S, Pocard M, Quenet F, Fushita S. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience. Ann Surg Oncol. 2018 May; 25(5):1184-1192. PMID: 29484565.
      View in: PubMed
    4. Reghunathan M, Kelly KJ, Valasek MA, Lowy AM, Baumgartner J. Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC. Ann Surg Oncol. 2018 Mar; 25(3):702-708. PMID: 29282599.
      View in: PubMed
    5. Riviere P, Fanta PT, Ikeda S, Baumgartner J, Heestand GM, Kurzrock R. The Mutational Landscape of Gastrointestinal Malignancies as Reflected by Circulating Tumor DNA. Mol Cancer Ther. 2018 Jan; 17(1):297-305. PMID: 29133621.
      View in: PubMed
    6. Kelly KJ, Cajas L, Baumgartner J, Lowy AM. Factors Associated with 60-Day Readmission Following Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2018 Jan; 25(1):91-97. PMID: 29090402.
      View in: PubMed
    7. Baumgartner J, McKenzie S, Block S, Costantini TW, Lowy AM. Prophylactic enoxaparin doses may be inadequate in patients undergoing abdominal cancer surgery. J Surg Res. 2018 Jan; 221:183-189. PMID: 29229126.
      View in: PubMed
    8. Valasek MA, Thung I, Gollapalle E, Hodkoff AA, Kelly KJ, Baumgartner J, Vavinskaya V, Lin GY, Tipps AP, Hosseini MV, Lowy AM. Overinterpretation is common in pathological diagnosis of appendix cancer during patient referral for oncologic care. PLoS One. 2017; 12(6):e0179216. PMID: 28591173.
      View in: PubMed
    9. VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AK, Gross C, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H, Hurria A. NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. J Natl Compr Canc Netw. 2016 11; 14(11):1357-1370. PMID: 27799507.
      View in: PubMed
    10. Vavinskaya V, Baumgartner J, Ko A, Saenz CC, Valasek MA. Low-Grade Appendiceal Mucinous Neoplasm Involving the Endometrium and Presenting with Mucinous Vaginal Discharge. Case Rep Obstet Gynecol. 2016; 2016:6841989. PMID: 27843660.
      View in: PubMed
    11. Unkart JT, Reid CM, Baumgartner J, Wallace AM, Kelly CJ. Are self-identified "disadvantaged" students less likely to enter surgical residencies? A single-institution study. J Surg Res. 2016 05 15; 202(2):253-8. PMID: 27229098.
      View in: PubMed
    12. Baumgartner J, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM. A Novel Tool for Predicting Major Complications After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. Ann Surg Oncol. 2016 May; 23(5):1609-17. PMID: 26678406.
      View in: PubMed
    13. Marmor RA, Kelly KJ, Lowy AM, Baumgartner J. Laparoscopy is Safe and Accurate to Evaluate Peritoneal Surface Metastasis Prior to Cytoreductive Surgery. Ann Surg Oncol. 2016 May; 23(5):1461-7. PMID: 26542584.
      View in: PubMed
    14. Murphy JD, Ma GL, Baumgartner J, Madlensky L, Burgoyne AM, Tang CM, Martinez ME, Sicklick JK. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study. Cancer. 2015 Sep 01; 121(17):2960-7. PMID: 25930983; PMCID: PMC4545693.
    15. Kelly KJ, Baumgartner J, Lowy AM. Laparoscopic evacuation of mucinous ascites for palliation of pseudomyxoma peritonei. Ann Surg Oncol. 2015 May; 22(5):1722-5. PMID: 25395145.
      View in: PubMed
    16. Baumgartner J, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015 May; 22(5):1716-21. PMID: 25145504.
      View in: PubMed
    17. Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner J, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spiliotis J, Torres-Melero J, Turaga K, Trout R. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol. 2014 Dec; 110(7):779-85. PMID: 25088304.
      View in: PubMed
    18. Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner J, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis. Ann Surg Oncol. 2014 Dec; 21(13):4195-201. PMID: 24854493.
      View in: PubMed
    19. Tran Cao HS, Lopez N, Chang DC, Lowy AM, Bouvet M, Baumgartner J, Talamini MA, Sicklick JK. Improved perioperative outcomes with minimally invasive distal pancreatectomy: results from a population-based analysis. JAMA Surg. 2014 Mar; 149(3):237-43. PMID: 24402232; PMCID: PMC4383084.
    20. Baumgartner J, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA. Aggressive locoregional management of recurrent peritoneal sarcomatosis. J Surg Oncol. 2013 Mar; 107(4):329-34. PMID: 23386388.
      View in: PubMed
    21. Baumgartner J, Krasinskas A, Daouadi M, Zureikat A, Marsh W, Lee K, Bartlett D, Moser AJ, Zeh HJ. Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenocarcinoma following neoadjuvant therapy. J Gastrointest Surg. 2012 Jun; 16(6):1152-9. PMID: 22399269.
      View in: PubMed
    22. Baumgartner J, Jordan KR, Hu LJ, Wilson CC, Banerjee A, McCarter MD. DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors. J Surg Res. 2012 Jul; 176(1):301-8. PMID: 21962733; PMCID: PMC4674430.
    23. Baumgartner J, Nydam TL, Clarke JH, Banerjee A, Silliman CC, McCarter MD. Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells. J Interferon Cytokine Res. 2009 Jun; 29(6):333-8. PMID: 19441884; PMCID: PMC2956619.
    24. Baumgartner J, McCarter MD. Suppressing the suppressor: Role of immunosuppressive regulatory T cells in cancer surgery. Surgery. 2009 Apr; 145(4):345-50. PMID: 19303982.
      View in: PubMed
    25. Baumgartner J, Silliman CC, Moore EE, Banerjee A, McCarter MD. Stored red blood cell transfusion induces regulatory T cells. J Am Coll Surg. 2009 Jan; 208(1):110-9. PMID: 19228512.
      View in: PubMed
    26. Baumgartner J, Gonzalez R, Lewis KD, Robinson WA, Richter DA, Palmer BE, Wilson CC, McCarter MD. Increased survival from stage IV melanoma associated with fewer regulatory T Cells. J Surg Res. 2009 Jun 01; 154(1):13-20. PMID: 19062042.
      View in: PubMed